Lexeo Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Lexeo Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2022 to Q2 2024.
  • Lexeo Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.64 USD/shares, a 92.3% increase year-over-year.
  • Lexeo Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 6.07 USD/shares.
  • Lexeo Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -12.4 USD/shares, a 65.9% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.07 -$1 +$7.66 +92.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$2 -$1 +$10.80 +93.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$12 $19.80 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$12 -$2 -19.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 -$8 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$12 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 -$10 Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.